Pulse lineResearch With Heart Logo

ARIC Publications

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
F
Fang M, Wang D, Tang O, Selvin E. "Prevalence of Chronic Disease in Laboratory-Confirmed COVID-19 Cases and U.S. Adults (2017-2018)." Diabetes Care. 2020;43(10):e127-e128.
Fang M, Ishigami J, Echouffo-Tcheugui JB, Lutsey PL, Pankow JS, Selvin E. "Diabetes and the risk of hospitalisation for infection: the Atherosclerosis Risk in Communities (ARIC) study." Diabetologia. 2021.
Fang M, Tcheugui JBEchouffo, Pankow JS, B Windham G, Selvin E. "Patient-reported preventive care practices in older adults with diabetes." Diabet Med. 2021;38(3):e14508.
Fanola CL, Norby FL, Shah AM, et al. "Incident Heart Failure and Long-Term Risk for Venous Thromboembolism." J Am Coll Cardiol. 2020;75(2):148-158.
Faridi KF, Zhao D, Martin SS, et al. "Serum vitamin D and change in lipid levels over 5 y: The Atherosclerosis Risk in Communities study." Nutrition. 2017;38:85-93.
Farlow JL, Robak LA, Hetrick K, et al. "Whole-Exome Sequencing in Familial Parkinson Disease." JAMA Neurol. 2016;73(1):68-75.
Fashanu OE, Norby FL, Aguilar D, et al. "Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study." Am Heart J. 2017;192:19-25.
Fashanu OE, Folsom AR, Oyenuga A, Ballantyne CM, Lutsey PL. "Galectin-3 and the incidence of abdominal aortic aneurysm: the atherosclerosis risk in communities (ARIC) study." Am J Cardiovasc Dis. 2017;7(6):114-121.
Fashanu OE, Heckbert SR, Aguilar D, et al. "Galectin-3 and Venous Thromboembolism Incidence: the Atherosclerosis Risk in Communities (ARIC) Study." Res Pract Thromb Haemost. 2017;1(2):223-230.
Fashanu OE, Zhao D, Schneider ALC, et al. "Mid-life serum Vitamin D concentrations were associated with incident dementia but not late-life neuropsychological performance in the Atherosclerosis Risk in Communities (ARIC) Study." BMC Neurol. 2019;19(1):244.
Fass R, Quan SF, O'Connor GT, Ervin A, Iber C. "Predictors of heartburn during sleep in a large prospective cohort study." Chest. 2005;127(5):1658-66.
Faulkner KM, Dickson VVaughan, Fletcher J, et al. "Factors Associated With Cognitive Impairment in Heart Failure With Preserved Ejection Fraction." J Cardiovasc Nurs. 2020.
Federspiel JJ, Sueta CA, Kucharska-Newton AMaria, et al. "Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study." J Eval Clin Pract. 2018;24(1):48-55.
Fedorowski A, Franceschini N, Brody J, et al. "Orthostatic hypotension and novel blood pressure-associated gene variants: Genetics of Postural Hemodynamics (GPH) Consortium." Eur Heart J. 2012;33(18):2331-41.
Feitosa MF, Kraja AT, Chasman DI, et al. "Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries." PLoS One. 2018;13(6):e0198166.
Feofanova EV, Yu B, Metcalf GA, et al. "Sequence-Based Analysis of Lipid-Related Metabolites in a Multiethnic Study." Genetics. 2018;209(2):607-616.
Feofanova EV, Lim E, Chen H, et al. "Exome sequence association study of levels and longitudinal change of cardiovascular risk factor phenotypes in European Americans and African Americans from the Atherosclerosis Risk in Communities Study." Genet Epidemiol. 2021;45(6):651-663.
Feofanova EV, Chen H, Dai Y, et al. "A Genome-wide Association Study Discovers 46 Loci of the Human Metabolome in the Hispanic Community Health Study/Study of Latinos." Am J Hum Genet. 2020;107(5):849-863.
Ferdinands JM, Mannino DM, Gwinn ML, Bray MS. "ADRB2 Arg16Gly polymorphism, lung function, and mortality: results from the Atherosclerosis Risk in Communities study." PLoS One. 2007;2(3):e289.
Ferket BS, van Kempen BJH, Wieberdink RG, et al. "Separate prediction of intracerebral hemorrhage and ischemic stroke." Neurology. 2014;82(20):1804-12.
Fernandes-Silva MM, Shah AM, Hegde S, et al. "Race-Related Differences in Left Ventricular Structural and Functional Remodeling in Response to Increased Afterload: The ARIC Study." JACC Heart Fail. 2017;5(3):157-165.
Fernandes-Silva MM, Shah AM, Claggett B, et al. "Adiposity, body composition and ventricular-arterial stiffness in the elderly: the Atherosclerosis Risk in Communities Study." Eur J Heart Fail. 2018;20(8):1191-1201.
Fernández-Rhodes L, Gong J, Haessler J, et al. "Trans-ethnic fine-mapping of genetic loci for body mass index in the diverse ancestral populations of the Population Architecture using Genomics and Epidemiology (PAGE) Study reveals evidence for multiple signals at established loci." Hum Genet. 2017;136(6):771-800.
Fernández-Rhodes L, Malinowski JR, Wang Y, et al. "The genetic underpinnings of variation in ages at menarche and natural menopause among women from the multi-ethnic Population Architecture using Genomics and Epidemiology (PAGE) Study: A trans-ethnic meta-analysis." PLoS One. 2018;13(7):e0200486.
Ferrario M, Carpenter MA, Chambless LE. "Reliability of body fat distribution measurements. The ARIC Study baseline cohort results. Atherosclerosis Risk in Communities Study." Int J Obes Relat Metab Disord. 1995;19(7):449-57.
Fesinmeyer MD, North KE, Lim U, et al. "Effects of smoking on the genetic risk of obesity: the population architecture using genomics and epidemiology study." BMC Med Genet. 2013;14:6.
Fesinmeyer MD, North KE, Ritchie MD, et al. "Genetic risk factors for BMI and obesity in an ethnically diverse population: results from the population architecture using genomics and epidemiology (PAGE) study." Obesity (Silver Spring). 2013;21(4):835-46.
Fesinmeyer MD, Meigs JB, North KE, et al. "Genetic variants associated with fasting glucose and insulin concentrations in an ethnically diverse population: results from the Population Architecture using Genomics and Epidemiology (PAGE) study." BMC Med Genet. 2013;14:98.
Filion KB, Agarwal SK, Ballantyne CM, et al. "High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study." Am Heart J. 2015;169(1):31-8.e3.
Filshtein TJ, Li X, Zimmerman SC, Ackley SF, M Glymour M, Power MC. "Proof of Concept Example for Use of Simulation to Allow Data Pooling Despite Privacy Restrictions." Epidemiology. 2021;32(5):638-647.
Flannick J, Mercader JM, Fuchsberger C, et al. "Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls." Nature. 2019;570(7759):71-76.
Fletcher G, Alam AB, Li L, et al. "Association of physical activity with the incidence of atrial fibrillation in persons > 65 years old: the Atherosclerosis Risk in Communities (ARIC) study." BMC Cardiovasc Disord. 2022;22(1):196.
Fletcher-Lloyd N, Soreq E, Wilson D, Nilforooshan R, Sharp DJ, Barnaghi P. "Home monitoring of daily living activities and prediction of agitation risk in a cohort of people living with dementia." Alzheimers Dement. 2021;17 Suppl 12:e058614.
Florido R, Lee AK, McEvoy JW, et al. "Cancer Survivorship and Subclinical Myocardial Damage." Am J Epidemiol. 2019;188(12):2188-2195.
Florido R, Zhao D, Ndumele CE, et al. "Physical Activity, Parental History of Premature Coronary Heart Disease, and Incident Atherosclerotic Cardiovascular Disease in the Atherosclerosis Risk in Communities (ARIC) Study." J Am Heart Assoc. 2016;5(9).
Florido R, Kwak L, Lazo M, et al. "Physical Activity and Incident Heart Failure in High-Risk Subgroups: The ARIC Study." J Am Heart Assoc. 2020;9(10):e014885.
Florido R, Daya NR, Ndumele CE, et al. "Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study." J Am Coll Cardiol. 2022;80(1):22-32.
Florido R, Ndumele CE, Kwak L, et al. "Physical Activity, Obesity, and Subclinical Myocardial Damage." JACC Heart Fail. 2017;5(5):377-384.
Florido R, Kwak L, Echouffo-Tcheugui JB, et al. "Obesity, Galectin-3, and Incident Heart Failure: The ARIC Study." J Am Heart Assoc. 2022;11(9):e023238.
Florido R, Kwak L, Lazo M, et al. "Six-Year Changes in Physical Activity and the Risk of Incident Heart Failure: ARIC Study." Circulation. 2018;137(20):2142-2151.
Floyd JS, Bloch KM, Brody JA, et al. "Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing." PLoS One. 2019;14(6):e0218115.
Folsom AR, Peacock JM, Demerath E, Boerwinkle E. "Variation in ANGPTL4 and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study." Metabolism. 2008;57(11):1591-6.
Folsom AR, Desvarieux M, Nieto JF, Boland LL, Ballantyne CM, Chambless LE. "B vitamin status and inflammatory markers." Atherosclerosis. 2003;169(1):169-74.
Folsom AR, Aleksic N, Ahn C, Boerwinkle E, Wu KK. "Beta-fibrinogen gene -455G/A polymorphism and coronary heart disease incidence: the Atherosclerosis Risk in Communities (ARIC) Study." Ann Epidemiol. 2001;11(3):166-70.
Folsom AR, Chambless LE, Duncan BB, Gilbert AC, Pankow JS. "Prediction of coronary heart disease in middle-aged adults with diabetes." Diabetes Care. 2003;26(10):2777-84.
Folsom AR, Roetker NS, Rosamond WD, Heckbert SR, Basu S, Cushman M. "Serum 25-hydroxyvitamin D and risk of venous thromboembolism: the Atherosclerosis Risk in Communities (ARIC) Study." J Thromb Haemost. 2014;12(9):1455-60.
Folsom AR, Rasmussen ML, Chambless LE, et al. "Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Diabetes Care. 1999;22(7):1077-83.
Folsom AR, Lutsey PL, Astor BC, Cushman M. "C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort." Thromb Haemost. 2009;102(4):615-9.
Folsom AR, Nieto FJ, Sorlie P, Chambless LE, Graham DY. "Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators." Circulation. 1998;98(9):845-50.
Folsom AR, Roetker NS, Kelley ST, Tang W. "Failure to replicate thrombomodulin genetic variant predictors of venous thromboembolism in African Americans." Blood. 2017;130(5):688-690.
Folsom AR, Lutsey PL, Astor BC, Wattanakit K, Heckbert SR, Cushman M. "Chronic kidney disease and venous thromboembolism: a prospective study." Nephrol Dial Transplant. 2010;25(10):3296-301.
Folsom AR, Tang W, George KM, Heckbert SR, Maclehose RF, Cushman M. "Prospective study of γ' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE)." Thromb Res. 2016;139:44-9.
Folsom AR, Olson NC, Lutsey PL, Roetker NS. "American Heart Association's Life's Simple 7 and incidence of venous thromboembolism." Am J Hematol. 2015;90(5):E92.
Folsom AR, Lutsey PL, Misialek JR. "A prospective study of migraine history and venous thromboembolism in older adults." Res Pract Thromb Haemost. 2019;3(3):357-363.
Folsom AR, Peacock JM, Nieto FJ, et al. "Plasma fibrinogen and incident hypertension in the Atherosclerosis Risk in Communities (ARIC) Study." J Hypertens. 1998;16(11):1579-83.
Folsom AR, Lutsey PL, Nambi V, Defilippi CR, Heckbert SR, Cushman M. "Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE)." Vasc Med. 2014;19(1):33-41.
Folsom AR, Lutsey PL, Heckbert SR, et al. "Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism." J Thromb Haemost. 2018;16(10):1964-1972.
Folsom AR, Pankow JS, Peacock JM, Bielinski SJ, Heiss G, Boerwinkle E. "Variation in TCF7L2 and increased risk of colon cancer: the Atherosclerosis Risk in Communities (ARIC) Study." Diabetes Care. 2008;31(5):905-9.
Folsom AR, Golden S H, Boland LL, Szklo M. "Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women." Eur J Epidemiol. 2005;20(12):1015-22.
Folsom AR, Ohira T, Yamagishi K, Cushman M. "Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study." J Thromb Haemost. 2009;7(11):1774-8.
Folsom AR, Tang W, Roetker NS, Heckbert SR, Cushman M. "Prospective study of circulating factor XI and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE)." Am J Hematol. 2015;90(11):1047-51.
Folsom AR, Rosamond WD, Shahar E, et al. "Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Circulation. 1999;100(7):736-42.
Folsom AR, Alonso A, George KM, Roetker NS, Tang W. "Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study." Thromb Res. 2015;136(4):781-5.
Folsom AR, Cushman M, Heckbert SR, Rosamond WD, Aleksic N. "Prospective study of fibrinolytic markers and venous thromboembolism." J Clin Epidemiol. 2003;56(6):598-603.
Folsom AR, Gottesman RF, Appiah D, Shahar E. "Plasma d-Dimer and Incident Ischemic Stroke and Coronary Heart Disease: The Atherosclerosis Risk in Communities Study." Stroke. 2016;47(1):18-23.
Folsom AR, Burke GL, Byers CL, et al. "Implications of obesity for cardiovascular disease in blacks: the CARDIA and ARIC studies." Am J Clin Nutr. 1991;53(6 Suppl):1604S-1611S.
Folsom AR. "Hemostatic risk factors for atherothrombotic disease: an epidemiologic view." Thromb Haemost. 2001;86(1):366-73.
Folsom AR, Lutsey PL, Roetker NS, Ballantyne CM, Hoogeveen RC, Rosamond WD. "Lipoprotein-associated phospholipase A2 and venous thromboembolism: a prospective study." Thromb Res. 2013;132(1):44-6.
Folsom AR, Ma J, McGovern PG, Eckfeldt H. "Relation between plasma phospholipid saturated fatty acids and hyperinsulinemia." Metabolism. 1996;45(2):223-8.
Folsom AR, Yatsuya H, Mosley TH, Psaty BM, Longstreth WT. "Risk of intraparenchymal hemorrhage with magnetic resonance imaging-defined leukoaraiosis and brain infarcts." Ann Neurol. 2012;71(4):552-9.
Folsom AR, Alonso A, Misialek JR, et al. "Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities (ARIC) study." Am Heart J. 2014;168(3):296-302.
Folsom AR, de Vries PS, Cushman M. "No prospective association of a polygenic risk score for coronary artery disease with venous thromboembolism incidence." J Thromb Haemost. 2021.
Folsom AR, Yatsuya H, Nettleton JA, Lutsey PL, Cushman M, Rosamond WD. "Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence." J Am Coll Cardiol. 2011;57(16):1690-6.
Folsom AR, Aleksic N, Wang L, Cushman M, Wu KK, White RH. "Protein C, antithrombin, and venous thromboembolism incidence: a prospective population-based study." Arterioscler Thromb Vasc Biol. 2002;22(6):1018-22.
Folsom AR, Ma J, Eckfeldt JH, Nieto FJ, Metcalf PA, Barnes RW. "Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima-media thickness. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Ann Epidemiol. 1995;5(3):186-91.
Folsom AR, Aleksic N, Sanhueza A, Boerwinkle E. "Risk factor correlates of platelet and leukocyte markers assessed by flow cytometry in a population-based sample." Atherosclerosis. 2009;205(1):272-8.
Folsom AR, Nambi V, Pankow JS, et al. "Effect of 9p21 genetic variation on coronary heart disease is not modified by other risk markers. The Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2012;224(2):435-9.
Folsom AR, Chambless LE, Ballantyne CM, et al. "An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study." Arch Intern Med. 2006;166(13):1368-73.
Folsom AR, Lutsey PL, Roetker NS, et al. "Elevated hepatic enzymes and incidence of venous thromboembolism: a prospective study." Ann Epidemiol. 2014;24(11):817-821.e2.
Folsom AR, Evans GW, Carr JJ, Stillman AE. "Association of traditional and nontraditional cardiovascular risk factors with coronary artery calcification." Angiology. 2004;55(6):613-23.

Pages